Bioprinting is the process of using cells and biological material (called bioinks) for 3D printing structures that allow living cells to multiply and grow. The technology can be applied across multiple uses, including organ replacement, cosmetic surgery, and drug development. 

Advances in 3D printing technology have made bioprinting devices commercially viable. Bioprinting can be done using a range of methods, including magnetic levitation as well as inkjet-based, syringe-based, and laser-based printing. Going forward, its development will be focused on bioprinting devices and bioink materials, as having viable materials that can be safely implanted and used in the human body is key to the success of the industry. From a demand perspective, one of the primary drivers is the shrinking number of organ donors, along with population growth and the prevalence of chronic conditions that could be treated through organ and tissue replacement. 

Note: Additional sections (such as market sizing, detailed overview, and incumbents) can be provided on request.